Non-graft-versus-host disease ocular complications after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation Review
| Authors: | Inamoto, Y.; Petriček, I.; Burns, L.; Chhabra, S.; DeFilipp, Z.; Hematti, P.; Rovó, A.; Schears, R.; Shah, A.; Agrawal, V.; Ahmed, A.; Ahmed, I.; Ali, A.; Aljurf, M.; Alkhateeb, H.; Beitinjaneh, A.; Bhatt, N.; Buchbinder, D.; Byrne, M.; Callander, N.; Fahnehjelm, K.; Farhadfar, N.; Gale, R. P.; Ganguly, S.; Hashmi, S.; Hildebrandt, G. C.; Horn, E.; Jakubowski, A.; Kamble, R. T.; Law, J.; Lee, C.; Nathan, S.; Penack, O.; Pingali, R.; Prasad, P.; Pulanic, D.; Rotz, S.; Shreenivas, A.; Steinberg, A.; Tabbara, K.; Tichelli, A.; Wirk, B.; Yared, J.; Basak, G. W.; Battiwalla, M.; Duarte, R.; Savani, B. N.; Flowers, M. E. D.; Shaw, B. E.; Valdés-Sanz, N. |
| Review Title: | Non-graft-versus-host disease ocular complications after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation |
| Abstract: | Non-graft-versus-host disease (GVHD)ocular complications are generally uncommon after hematopoietic cell transplantation (HCT)but can cause prolonged morbidity affecting activities of daily living and quality of life. Here we provide an expert review of non-GVHD ocular complications in a collaboration between transplantation physicians and ophthalmologists through the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation. Complications discussed in this review include cataracts, glaucoma, ocular infections, ocular involvement with malignancy, ischemic microvascular retinopathy, central retinal vein occlusion, retinal hemorrhage, retinal detachment and ocular toxicities associated with medications. We summarize the incidence, risk factors, screening, prevention, and treatment of individual complications and generate evidence-based recommendations. Baseline ocular evaluation before HCT should be considered in all patients who undergo HCT. Follow-up evaluations should be considered according to clinical signs and symptoms and risk factors. Better preventive strategies and treatments remain to be investigated for individual ocular complications after HCT. Both transplantation physicians and ophthalmologists should be knowledgeable about non-GVHD ocular complications and provide comprehensive collaborative team care. © 2018 American Society for Blood and Marrow Transplantation |
| Keywords: | pathogenesis; review; treatment; follow up; quality of life; evidence based practice; risk factor; graft versus host reaction; hematopoietic cell; cataract; retina detachment; retina hemorrhage; retinopathy; daily life activity; eye disease; glaucoma; eye toxicity; eye infection; cell transplantation; eye; hematocrit; prevention; hematopoietic cell transplantation; complication; human; central retina vein occlusion; ischemic microvascular retinopathy |
| Journal Title: | Biology of Blood and Marrow Transplantation |
| Volume: | 25 |
| Issue: | 5 |
| ISSN: | 1083-8791 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2019-05-01 |
| Start Page: | e145 |
| End Page: | e154 |
| Language: | English |
| DOI: | 10.1016/j.bbmt.2018.11.033 |
| PUBMED: | 30521975 |
| PROVIDER: | scopus |
| PMCID: | PMC6511311 |
| DOI/URL: | |
| Notes: | Review -- Source: Scopus |
